| IORMX | PCDPX | IORMX / PCDPX | |
| Total Expense Ratio | 0.52 | 0.43 | 121% |
| Annual Report Gross Expense Ratio | 0.52 | 0.43 | 121% |
| Fund Existence | 7 years | 18 years | - |
| Gain YTD | 3.556 | 3.661 | 97% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 1000000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.44B | 209M | 689% |
| Annual Yield % from dividends | 3.72 | 2.77 | 134% |
| Returns for 1 year | 2.41 | 3.60 | 67% |
| Returns for 3 years | 11.36 | 10.39 | 109% |
| Returns for 5 years | 7.86 | 6.85 | 115% |
| Returns for 10 years | N/A | 14.13 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AMTOX | 10.52 | 0.08 | +0.77% |
| AB All Market Real Return 1 | |||
| FSTKX | 36.06 | 0.21 | +0.59% |
| Federated Hermes MDT Large Cap Value Svc | |||
| PEUCX | 43.00 | 0.17 | +0.40% |
| Principal Equity Income C | |||
| MYITX | 10.26 | 0.04 | +0.39% |
| NYLI WMC International Research Eq Cl A | |||
| GTTMX | 21.06 | 0.06 | +0.29% |
| Glenmede Total Market Plus Eq Ptf | |||